is phentermine a glp-1 receptor agonist vs Ozempic Understanding Weight Loss Medications: GLP-1

Data and clinical observation support three primary pillars: Abortive intervention for acute disruption

55 , e70000 (2025)

[DOI] [PMC free article] [PubMed] [Google Scholar] 9.Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity: the STEP 4 randomized clinical trial

Those are the lifestyle changes you have to put in place in parallel

The Australian and New Zealand College of Anaesthetists (ANZCA) and peak diabetes, obesity and gastroenterological bodies have updated recommendations, frequently asked questions (FAQs) and patient information for clinicians when talking to patients using GLP-1/GIP receptor agonists